Evidence map›Paper›PMID 27422988›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2016

Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries.

Sheila Flavahan, Fumin Chang, Nicholas A Flavahan

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Direct Vascular Effects of Angiotensin II (A Systematic Short Review).International journal of molecular sciences · 2024
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer's Disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
    Article
  6. Benefits of exercise training on cerebrovascular and cognitive function in ageing.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Review
  7. Article
  8. Proinflammation, profibrosis, and arterial aging.Aging medicine (Milton (N.S.W)) · 2020
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Age-related impairment of metabovascular coupling during cortical spreading depolarizations.American journal of physiology. Heart and circulatory physiology · 2017
    Article
  16. Article
  17. In Development-A New Paradigm for Understanding Vascular Disease.Journal of cardiovascular pharmacology · 2017
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sheila FlavahanDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
Fumin ChangDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
Nicholas A FlavahanDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland nflavah1@jhmi.edu.
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Impaired Endothelial Maturation and the Developmental Origin of Vascular DiseaseR01HD078639 · NICHD · JOHNS HOPKINS UNIVERSITY · PI FLAVAHAN, NICHOLAS A · 2014 to 2018
$1.7M
NICHD NIH HHS R01 HD078639
6 · The paper itself

Abstract

Aging impairs endothelium-dependent NO-mediated dilatation, which results from increased production of reactive oxygen species (ROS). The local generation of angiotensin II (ANG II) is increased in aging arteries and contributes to inflammatory and fibrotic activity of smooth muscle cells and arterial wall remodeling. Although prolonged in vivo ANG II inhibition improves the impaired endothelial dilatation of aging arteries, it is unclear whether this reflects inhibition of intravascular or systemic ANG II systems. Experiments were therefore performed on isolated tail arteries from young (3-4 mo) and old (22-24 mo) F344 rats to determine if a local renin-angiotensin system contributes to the endothelial dilator dysfunction of aging. Aging impaired dilatation to the endothelial agonist acetylcholine but did not influence responses to a nitric oxide (NO) donor (DEA NONOate). Dilatation to acetylcholine was greatly reduced by NO synthase inhibition [nitro-l-arginine methyl ester (l-NAME)] in young and old arteries. In isolated arteries, acute inhibition of angiotensin-converting enzyme (ACE) (perindoprilat), renin (aliskiren), or AT1 receptors (valsartan, losartan) did not influence dilatation to acetylcholine in young arteries but increased responses in old arteries. After ANG II inhibition, the dilator response to acetylcholine was similar in young and old arteries. ROS activity, which was increased in endothelium of aging arteries, was also reduced by inhibiting ANG II (perindoprilat, losartan). Renin expression was increased by 5.6 fold and immunofluorescent levels of ANG II were confirmed to be increased in aging compared with young arteries. Exogenous ANG II inhibited acetylcholine-induced dilatation. Therefore, aging-induced impairment of endothelium-dependent dilatation in aging is caused by a local intravascular renin-angiotensin system.

Indexed as

AgingAdrenergic alpha-1 Receptor AgonistsAmidesAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersAnimalsAntihypertensive AgentsArteriesEndothelium, VascularEnzyme InhibitorsFumaratesIndolesMaleNG-Nitroarginine Methyl EsterNitric Oxide SynthasePhenylephrineAdrenergic alpha-1 Receptor AgonistsaliskirenAmidesAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsEnzyme InhibitorsFumaratesIndolesNG-Nitroarginine Methyl EsterNitric Oxide SynthaseperindoprilatPhenylephrineRenin InhibitorsValsartanagingAT1 receptorsendotheliumkeywords. angiotensin ii

Identifiers

PMID27422988
PMCPMC5504433
OpenAlexW2472191294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.